Virginia Biosciences Health Research Corporation Announces Ten-to-One Return on Investment and New Grant Funding to Support Neuroscience Initiatives

Virginia Biosciences Health Research Corporation (VBHRC/“the catalyst”) today announced that it is accepting applications/letters of intent (LOIs) for Round 7 of grants to fund the development, validation and application of new approaches to diagnosing, preventing and treating neurological conditions, including brain injuries, brain developmental disorders, neurodegenerative disorders, neuropsychiatric and behavioral disorders, as well as addiction and substance abuse. The awards, which range from $200,000 to $800,000, will accelerate translational research in the Commonwealth of Virginia through collaborations between industry and Virginia research universities.

The deadline for consideration is June 8, 2017. Applications/LOIs and grant criteria can be downloaded from the VBHRC website (www.vbhrc.com).

“VBHRC’s seventh round of funding provides us an opportunity to continue our focus on neurological issues that will lead to a better understanding of how the brain works,” said Mike Grisham, CEO, VBHRC/“the catalyst.” “This enables us to research and address disorders of the brain including Traumatic Brain Injuries, Autism, ALS, Alzheimer’s, Parkinson’s, mental health, addiction and postdeployment issues faced by our military. Virginia’s healthcare systems, universities and industry partners – in conjunction with the Department of Veterans Affairs – provide some of the most collaborative and innovative translational research programs in the country. This funding, provided by the Virginia General Assembly, will help accelerate this important research.”

Read the full press release.